Tag: Neuraptive Therapeutics

Neuraptive Therapeutics Inc. Receives Orphan Drug Designation for its Lead Development Asset

Neuraptive Therapeutics Receives Orphan Drug Designation from the FDA for NTX-001 in Peripheral Nerve Injury Treatment Wayne, PA – Neuraptive Therapeutics Inc., a pioneering biotechnology...

Neuraptive Therapeutics, Inc. Announces Achievement of Proof of Concept in The NEUROFUSE Study of NTX-001 for the Adjunct Treatment of Transected Peripheral Nerves

Business Wire India The NEUROFUSE Study is an ongoing 48-week Multicenter, Randomized, evaluator-blinded, Phase 2a study in upper extremity nerve transections comparing NTX-001 adjunctive...

- A word from our sponsors -

HomeTagsNeuraptive Therapeutics

Kunal Kamra’s Controversial Joke Draws Strong Reactions from Maharashtra Politicians

Eid al-Fitr 2025: Understanding the Significance and Celebrations of This Joyous Festival

Scandal Erupts as Delhi Judge Faces Allegations of Hidden Cash Discovered During Fire Incident

Tag: Neuraptive Therapeutics

Neuraptive Therapeutics Inc. Receives Orphan Drug Designation for its Lead Development Asset

Neuraptive Therapeutics, Inc. Announces Achievement of Proof of Concept in The NEUROFUSE Study of NTX-001 for the Adjunct Treatment of Transected Peripheral Nerves

Follow us

Explore

Menu

Menu

Others

Follow us